用司库奇尤单抗成功治疗一名儿童下肢线状银屑病。 - Suppr | 超能文献

相似文献

1

Successful treatment with ixekizumab of lower-limb linear psoriasis in a child.用司库奇尤单抗成功治疗一名儿童下肢线状银屑病。

Ann Dermatol Venereol. 2022 Sep;149(3):216-218. doi: 10.1016/j.annder.2022.02.003. Epub 2022 Mar 10.

2

Ixekizumab for the treatment of psoriasis: up-to-date.依奇珠单抗治疗银屑病：最新进展。

Expert Opin Biol Ther. 2020 Jun;20(6):549-557. doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10.

3

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy.司库奇尤单抗治疗中重度斑块状银屑病的聚焦：设计、研发及治疗应用

Drug Des Devel Ther. 2017 Jun 2;11:1643-1651. doi: 10.2147/DDDT.S92128. eCollection 2017.

4

Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.司库奇尤单抗用于治疗中度至重度斑块状银屑病和银屑病关节炎的成人患者。

Expert Rev Clin Pharmacol. 2016 Nov;9(11):1423-1433. doi: 10.1080/17512433.2016.1242409. Epub 2016 Oct 11.

5

The successful treatment with ixekizumab in a multi-failure psoriasis patient.司库奇尤单抗成功治疗一名多系统功能衰竭的银屑病患者。

Dermatol Online J. 2018 Sep 10;24(9):13030/qt2qn1p4bz.

6

No need to change the drug class: ixekizumab- following secukinumab-therapy in psoriasis.无需改变药物类别：在银屑病中，司库奇尤单抗治疗后使用依奇珠单抗。

J Dermatolog Treat. 2019 May;30(3):216-220. doi: 10.1080/09546634.2018.1506081. Epub 2018 Sep 11.

7

A case of pediatric psoriasis successfully and rapidly treated with ixekizumab.一例使用司库奇尤单抗成功快速治疗的儿童银屑病病例。

Dermatol Ther. 2021 Nov;34(6):e15108. doi: 10.1111/dth.15108. Epub 2021 Aug 31.

8

A Review of Ixekizumab, an Anti-Interleukin-17A Monoclonal Antibody, for Moderate-to-Severe Plaque Psoriasis.抗白细胞介素-17A单克隆抗体司库奇尤单抗治疗中重度斑块状银屑病的综述

Skin Therapy Lett. 2016 Nov;21(6):1-6.

9

Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice.司库奇尤单抗（白细胞介素17A拮抗剂）：真实世界临床实践中的12周疗效和安全性结果

J Cutan Med Surg. 2019 Mar/Apr;23(2):174-177. doi: 10.1177/1203475418814229. Epub 2018 Nov 18.

10

Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema.一名患有严重银屑病的患者在使用司库奇尤单抗后发生湿疹，成功转换为使用布罗达单抗治疗。

Eur J Dermatol. 2020 Dec 1;30(6):732-734. doi: 10.1684/ejd.2020.3904.

引用本文的文献

1

Ustekinumab is effective in the treatment of linear psoriasis: a case report and literature review.乌司奴单抗治疗线状银屑病有效：1例病例报告及文献综述

Front Immunol. 2025 Apr 22;16:1553793. doi: 10.3389/fimmu.2025.1553793. eCollection 2025.

2

Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report.使用白细胞介素-17a拮抗剂司库奇尤单抗成功治疗线状银屑病：一例报告

Psoriasis (Auckl). 2025 Jan 21;15:23-28. doi: 10.2147/PTT.S499039. eCollection 2025.

3

Anti-tumor necrosis factor-alpha inhibitor-induced linear psoriasis: A case report.